| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 112 | 2024 | 13019 | 4.600 |
Why?
|
| Mutation | 131 | 2024 | 29717 | 3.090 |
Why?
|
| Adenocarcinoma | 50 | 2018 | 6347 | 2.900 |
Why?
|
| Genome, Human | 52 | 2021 | 4420 | 2.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 51 | 2023 | 5171 | 2.410 |
Why?
|
| Telomerase | 13 | 2023 | 729 | 2.210 |
Why?
|
| Neuroendocrine Tumors | 7 | 2022 | 594 | 2.130 |
Why?
|
| Genomics | 54 | 2023 | 5692 | 2.010 |
Why?
|
| Gene Dosage | 31 | 2017 | 1251 | 1.910 |
Why?
|
| Gene Expression Regulation, Neoplastic | 65 | 2021 | 8425 | 1.860 |
Why?
|
| Neoplasms | 62 | 2024 | 21596 | 1.800 |
Why?
|
| Loss of Heterozygosity | 20 | 2023 | 678 | 1.790 |
Why?
|
| Proto-Oncogene Proteins | 29 | 2023 | 4553 | 1.670 |
Why?
|
| DNA, Neoplasm | 26 | 2020 | 1758 | 1.670 |
Why?
|
| Carcinoma, Squamous Cell | 19 | 2023 | 4029 | 1.600 |
Why?
|
| Cell Transformation, Neoplastic | 29 | 2023 | 2940 | 1.590 |
Why?
|
| Gene Amplification | 23 | 2017 | 1062 | 1.520 |
Why?
|
| Tumor Suppressor Proteins | 19 | 2017 | 2842 | 1.410 |
Why?
|
| Fusobacterium nucleatum | 5 | 2020 | 160 | 1.390 |
Why?
|
| Protein Kinase Inhibitors | 32 | 2024 | 5522 | 1.370 |
Why?
|
| DNA Copy Number Variations | 26 | 2023 | 1940 | 1.370 |
Why?
|
| Colorectal Neoplasms | 17 | 2022 | 6754 | 1.250 |
Why?
|
| Fusobacterium | 3 | 2022 | 54 | 1.240 |
Why?
|
| Glioblastoma | 10 | 2024 | 3456 | 1.240 |
Why?
|
| Cell Line, Tumor | 87 | 2022 | 16665 | 1.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 28 | 2022 | 3585 | 1.210 |
Why?
|
| Intestinal Neoplasms | 3 | 2022 | 319 | 1.200 |
Why?
|
| Quinazolines | 26 | 2013 | 1355 | 1.180 |
Why?
|
| Oncogenes | 18 | 2023 | 1263 | 1.160 |
Why?
|
| Gene Expression Profiling | 48 | 2019 | 9410 | 1.150 |
Why?
|
| DNA Mutational Analysis | 36 | 2020 | 4187 | 1.120 |
Why?
|
| Gene Rearrangement | 10 | 2018 | 1179 | 1.050 |
Why?
|
| RNA-Binding Proteins | 8 | 2022 | 1899 | 1.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 9 | 2016 | 670 | 1.030 |
Why?
|
| Oncogene Proteins, Fusion | 11 | 2021 | 1581 | 1.000 |
Why?
|
| Chromosome Aberrations | 18 | 2023 | 1811 | 0.950 |
Why?
|
| Bradyrhizobium | 2 | 2013 | 19 | 0.940 |
Why?
|
| Sequence Analysis, DNA | 30 | 2022 | 4801 | 0.940 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 3 | 2021 | 20 | 0.940 |
Why?
|
| Aneuploidy | 6 | 2023 | 530 | 0.910 |
Why?
|
| Interferons | 4 | 2024 | 704 | 0.900 |
Why?
|
| Humans | 351 | 2024 | 742088 | 0.880 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2019 | 337 | 0.860 |
Why?
|
| Genes, Neoplasm | 10 | 2018 | 376 | 0.850 |
Why?
|
| Fusobacterium Infections | 1 | 2022 | 53 | 0.850 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 5 | 2023 | 250 | 0.850 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 21 | 2014 | 3920 | 0.840 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1337 | 0.830 |
Why?
|
| NIH 3T3 Cells | 13 | 2019 | 677 | 0.830 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 10 | 2021 | 1659 | 0.800 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2021 | 15494 | 0.790 |
Why?
|
| Receptors, Mitogen | 4 | 2015 | 62 | 0.790 |
Why?
|
| SOS1 Protein | 3 | 2019 | 41 | 0.780 |
Why?
|
| Alleles | 18 | 2021 | 6931 | 0.770 |
Why?
|
| Genes, erbB-1 | 6 | 2013 | 161 | 0.770 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2021 | 2948 | 0.770 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2020 | 245 | 0.760 |
Why?
|
| Ileal Neoplasms | 1 | 2020 | 21 | 0.750 |
Why?
|
| Adenosine Deaminase | 2 | 2021 | 241 | 0.740 |
Why?
|
| Opportunistic Infections | 2 | 2013 | 389 | 0.740 |
Why?
|
| Drug Resistance, Neoplasm | 19 | 2019 | 5163 | 0.720 |
Why?
|
| bcl-X Protein | 3 | 2019 | 411 | 0.720 |
Why?
|
| Software | 9 | 2022 | 4434 | 0.720 |
Why?
|
| Epitope Mapping | 1 | 2021 | 311 | 0.710 |
Why?
|
| Esophageal Neoplasms | 7 | 2022 | 1581 | 0.710 |
Why?
|
| Nuclear Proteins | 15 | 2023 | 5851 | 0.690 |
Why?
|
| Protein-Tyrosine Kinases | 11 | 2023 | 2455 | 0.690 |
Why?
|
| Pyridazines | 3 | 2021 | 201 | 0.690 |
Why?
|
| SOXB1 Transcription Factors | 4 | 2021 | 284 | 0.670 |
Why?
|
| Neoplasm Metastasis | 9 | 2018 | 4839 | 0.670 |
Why?
|
| INDEL Mutation | 2 | 2018 | 279 | 0.670 |
Why?
|
| Carcinoma, Small Cell | 6 | 2005 | 420 | 0.670 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2016 | 282 | 0.670 |
Why?
|
| Computational Biology | 17 | 2021 | 3518 | 0.660 |
Why?
|
| Marsupialia | 1 | 2018 | 26 | 0.650 |
Why?
|
| Translocation, Genetic | 3 | 2015 | 1417 | 0.640 |
Why?
|
| Germ-Line Mutation | 6 | 2023 | 1786 | 0.640 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 150 | 0.630 |
Why?
|
| Eukaryota | 1 | 2018 | 100 | 0.630 |
Why?
|
| Antineoplastic Agents | 32 | 2019 | 13655 | 0.620 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 6 | 2021 | 187 | 0.610 |
Why?
|
| ras Proteins | 6 | 2019 | 1060 | 0.610 |
Why?
|
| Polyomavirus | 3 | 2022 | 248 | 0.610 |
Why?
|
| Receptor, erbB-2 | 11 | 2023 | 2410 | 0.610 |
Why?
|
| Chromosome Breakpoints | 5 | 2014 | 98 | 0.590 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 969 | 0.590 |
Why?
|
| Fetal Blood | 2 | 2013 | 1317 | 0.580 |
Why?
|
| Pancreatic Neoplasms | 6 | 2023 | 5249 | 0.580 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2021 | 880 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2018 | 657 | 0.570 |
Why?
|
| Metronidazole | 1 | 2017 | 217 | 0.570 |
Why?
|
| Brain Neoplasms | 9 | 2021 | 8829 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 3 | 6 | 2018 | 323 | 0.560 |
Why?
|
| GATA6 Transcription Factor | 2 | 2013 | 50 | 0.560 |
Why?
|
| Cell Survival | 21 | 2021 | 5872 | 0.550 |
Why?
|
| Isocitrate Dehydrogenase | 4 | 2018 | 870 | 0.550 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2015 | 322 | 0.540 |
Why?
|
| Phosphorylation | 21 | 2019 | 8436 | 0.540 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2021 | 504 | 0.530 |
Why?
|
| RNA Interference | 10 | 2015 | 2890 | 0.530 |
Why?
|
| Colitis | 2 | 2013 | 1149 | 0.520 |
Why?
|
| Colon | 2 | 2013 | 1773 | 0.520 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.510 |
Why?
|
| Chromosome Deletion | 8 | 2018 | 1400 | 0.510 |
Why?
|
| Genes, Tumor Suppressor | 10 | 2023 | 1097 | 0.510 |
Why?
|
| RNA Splicing | 4 | 2022 | 907 | 0.510 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2021 | 2524 | 0.500 |
Why?
|
| Ovarian Neoplasms | 10 | 2023 | 4823 | 0.490 |
Why?
|
| Cyclin-Dependent Kinases | 8 | 2018 | 670 | 0.490 |
Why?
|
| Gene Deletion | 12 | 2018 | 2751 | 0.490 |
Why?
|
| Cell Lineage | 6 | 2023 | 2504 | 0.490 |
Why?
|
| Gene Fusion | 4 | 2017 | 371 | 0.490 |
Why?
|
| Databases, Genetic | 9 | 2021 | 1780 | 0.480 |
Why?
|
| Genome, Bacterial | 3 | 2018 | 754 | 0.480 |
Why?
|
| Transcription Factors | 19 | 2023 | 12164 | 0.480 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 1158 | 0.470 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2016 | 602 | 0.470 |
Why?
|
| PPAR gamma | 3 | 2022 | 493 | 0.470 |
Why?
|
| Neoplasm Proteins | 7 | 2018 | 3691 | 0.470 |
Why?
|
| Breast Neoplasms | 15 | 2023 | 20774 | 0.470 |
Why?
|
| Chromosome Inversion | 1 | 2014 | 127 | 0.460 |
Why?
|
| Cell Proliferation | 27 | 2019 | 10472 | 0.460 |
Why?
|
| Mutagenesis | 6 | 2020 | 1263 | 0.460 |
Why?
|
| Mice | 60 | 2021 | 81045 | 0.460 |
Why?
|
| Pyrimidinones | 1 | 2015 | 370 | 0.450 |
Why?
|
| High-Throughput Screening Assays | 3 | 2021 | 944 | 0.450 |
Why?
|
| Cerebellar Neoplasms | 6 | 2014 | 585 | 0.440 |
Why?
|
| Retroelements | 1 | 2014 | 164 | 0.440 |
Why?
|
| Apoptosis | 21 | 2022 | 9715 | 0.440 |
Why?
|
| Exons | 11 | 2018 | 2431 | 0.440 |
Why?
|
| Protein Multimerization | 3 | 2021 | 971 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase 6 | 5 | 2022 | 322 | 0.440 |
Why?
|
| STAT6 Transcription Factor | 1 | 2013 | 199 | 0.430 |
Why?
|
| Subtraction Technique | 2 | 2008 | 525 | 0.430 |
Why?
|
| DNA-Binding Proteins | 22 | 2015 | 9639 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2014 | 220 | 0.430 |
Why?
|
| RNA, Neoplasm | 8 | 2015 | 768 | 0.420 |
Why?
|
| Endometrial Neoplasms | 6 | 2014 | 1351 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2013 | 2502 | 0.420 |
Why?
|
| Signal Transduction | 40 | 2019 | 23387 | 0.420 |
Why?
|
| Cell Line | 22 | 2022 | 15994 | 0.420 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2013 | 72 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 1213 | 0.410 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 36 | 0.410 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2022 | 535 | 0.410 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 1057 | 0.410 |
Why?
|
| Animals | 75 | 2021 | 168561 | 0.410 |
Why?
|
| Mutation, Missense | 12 | 2015 | 2556 | 0.410 |
Why?
|
| Sequence Analysis, RNA | 7 | 2022 | 2011 | 0.410 |
Why?
|
| Xenograft Model Antitumor Assays | 10 | 2019 | 3557 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2015 | 2915 | 0.400 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 484 | 0.400 |
Why?
|
| HeLa Cells | 10 | 2021 | 3127 | 0.400 |
Why?
|
| Sequence Deletion | 9 | 2018 | 1526 | 0.390 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 11 | 2023 | 1683 | 0.390 |
Why?
|
| Protein Kinases | 6 | 2024 | 1638 | 0.390 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 154 | 0.390 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 381 | 0.390 |
Why?
|
| Proto-Oncogene Proteins B-raf | 13 | 2023 | 2028 | 0.390 |
Why?
|
| Astrocytoma | 1 | 2016 | 789 | 0.380 |
Why?
|
| Genome | 7 | 2021 | 1803 | 0.380 |
Why?
|
| Pyridones | 1 | 2015 | 712 | 0.380 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2010 | 379 | 0.380 |
Why?
|
| Glioma | 7 | 2018 | 3388 | 0.380 |
Why?
|
| Epigenesis, Genetic | 8 | 2016 | 3639 | 0.380 |
Why?
|
| Telomere | 6 | 2023 | 909 | 0.370 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1525 | 0.370 |
Why?
|
| RNA | 8 | 2022 | 2747 | 0.370 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2019 | 731 | 0.370 |
Why?
|
| Base Sequence | 19 | 2021 | 12797 | 0.370 |
Why?
|
| Mice, Nude | 10 | 2018 | 3689 | 0.360 |
Why?
|
| Cell Cycle | 7 | 2018 | 2964 | 0.360 |
Why?
|
| Medulloblastoma | 6 | 2012 | 681 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 2014 | 203 | 0.360 |
Why?
|
| DNA Damage | 7 | 2020 | 2423 | 0.350 |
Why?
|
| Genome, Viral | 3 | 2011 | 667 | 0.350 |
Why?
|
| Polyomavirus Infections | 3 | 2022 | 196 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 11 | 2014 | 3847 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2021 | 17400 | 0.350 |
Why?
|
| Histones | 5 | 2016 | 2597 | 0.350 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2009 | 1 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2019 | 987 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2019 | 578 | 0.340 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2009 | 17 | 0.340 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2009 | 119 | 0.340 |
Why?
|
| Cyclins | 5 | 2006 | 601 | 0.340 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 142 | 0.330 |
Why?
|
| Quinolines | 5 | 2007 | 719 | 0.330 |
Why?
|
| Genetic Variation | 6 | 2018 | 6540 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 374 | 0.330 |
Why?
|
| Arenavirus | 1 | 2008 | 7 | 0.330 |
Why?
|
| NF-E2-Related Factor 2 | 4 | 2015 | 364 | 0.320 |
Why?
|
| Molecular Sequence Data | 19 | 2014 | 18112 | 0.320 |
Why?
|
| Chromosome Mapping | 9 | 2012 | 4742 | 0.320 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4200 | 0.320 |
Why?
|
| Haplotypes | 5 | 2021 | 2781 | 0.320 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 5867 | 0.310 |
Why?
|
| Exoribonucleases | 2 | 2024 | 95 | 0.300 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2018 | 1144 | 0.300 |
Why?
|
| Phosphatidylinositol 3-Kinases | 10 | 2018 | 2938 | 0.300 |
Why?
|
| Spinal Cord | 1 | 2016 | 1807 | 0.300 |
Why?
|
| Female | 89 | 2023 | 379592 | 0.290 |
Why?
|
| Serine | 2 | 2011 | 828 | 0.290 |
Why?
|
| Homeodomain Proteins | 4 | 2013 | 2417 | 0.290 |
Why?
|
| Immunoblotting | 7 | 2015 | 1683 | 0.290 |
Why?
|
| Polymerase Chain Reaction | 11 | 2015 | 6171 | 0.280 |
Why?
|
| Tumor Burden | 5 | 2023 | 1905 | 0.280 |
Why?
|
| Genetic Heterogeneity | 5 | 2018 | 732 | 0.280 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2012 | 1086 | 0.280 |
Why?
|
| Transfection | 13 | 2019 | 5892 | 0.280 |
Why?
|
| Genome-Wide Association Study | 13 | 2015 | 12220 | 0.280 |
Why?
|
| Molecular Targeted Therapy | 8 | 2021 | 2723 | 0.280 |
Why?
|
| Protein Binding | 14 | 2021 | 9387 | 0.270 |
Why?
|
| Databases, Nucleic Acid | 3 | 2014 | 211 | 0.270 |
Why?
|
| Cluster Analysis | 15 | 2017 | 2713 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2021 | 2906 | 0.270 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 4 | 2017 | 170 | 0.270 |
Why?
|
| beta Catenin | 6 | 2015 | 1058 | 0.270 |
Why?
|
| Neoplasms, Experimental | 5 | 2016 | 1274 | 0.260 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2018 | 105 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.260 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2013 | 5425 | 0.260 |
Why?
|
| Catalytic Domain | 6 | 2021 | 699 | 0.260 |
Why?
|
| Organoids | 4 | 2021 | 692 | 0.260 |
Why?
|
| Cell Cycle Proteins | 6 | 2023 | 3444 | 0.260 |
Why?
|
| Genomic Structural Variation | 2 | 2018 | 65 | 0.260 |
Why?
|
| Transcription, Genetic | 15 | 2018 | 7721 | 0.260 |
Why?
|
| Open Reading Frames | 4 | 2020 | 810 | 0.260 |
Why?
|
| Melanoma | 9 | 2022 | 5462 | 0.260 |
Why?
|
| DNA, Concatenated | 1 | 2004 | 3 | 0.260 |
Why?
|
| 3' Untranslated Regions | 3 | 2021 | 508 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 2011 | 0.250 |
Why?
|
| RNA, Messenger | 7 | 2015 | 13029 | 0.250 |
Why?
|
| Enzyme Inhibitors | 7 | 2015 | 3800 | 0.250 |
Why?
|
| Proteins | 9 | 2023 | 6096 | 0.250 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 170 | 0.240 |
Why?
|
| Genomic Instability | 4 | 2018 | 695 | 0.240 |
Why?
|
| Male | 78 | 2022 | 349538 | 0.240 |
Why?
|
| Carcinoma | 4 | 2023 | 2374 | 0.240 |
Why?
|
| RNA, Small Interfering | 9 | 2018 | 3504 | 0.240 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 149 | 0.240 |
Why?
|
| Prostatic Neoplasms | 12 | 2020 | 11039 | 0.230 |
Why?
|
| Amino Acid Substitution | 6 | 2014 | 1792 | 0.230 |
Why?
|
| Genes, myc | 4 | 2018 | 399 | 0.230 |
Why?
|
| Chromosome Breakage | 2 | 2015 | 173 | 0.230 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2014 | 3123 | 0.230 |
Why?
|
| Karyotyping | 2 | 2008 | 1243 | 0.230 |
Why?
|
| Core Binding Factor beta Subunit | 2 | 2013 | 45 | 0.230 |
Why?
|
| Enzyme Activation | 11 | 2015 | 3701 | 0.230 |
Why?
|
| Precancerous Conditions | 2 | 2008 | 971 | 0.220 |
Why?
|
| RNA, Transfer, Leu | 1 | 2022 | 9 | 0.220 |
Why?
|
| Multigene Family | 4 | 2010 | 1102 | 0.220 |
Why?
|
| Serine Endopeptidases | 2 | 2010 | 1073 | 0.220 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2017 | 449 | 0.220 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 286 | 0.220 |
Why?
|
| DNA, Bacterial | 3 | 2018 | 1465 | 0.220 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2022 | 2229 | 0.210 |
Why?
|
| Protein Methyltransferases | 4 | 2006 | 55 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2014 | 318 | 0.210 |
Why?
|
| Genes, p53 | 3 | 2015 | 755 | 0.210 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 3564 | 0.210 |
Why?
|
| Repressor Proteins | 2 | 2013 | 3020 | 0.210 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 1114 | 0.210 |
Why?
|
| Kidney Neoplasms | 5 | 2021 | 4229 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2016 | 300 | 0.210 |
Why?
|
| Genetics, Microbial | 1 | 2002 | 60 | 0.210 |
Why?
|
| Nanopores | 1 | 2022 | 50 | 0.210 |
Why?
|
| Interferon-beta | 1 | 2024 | 323 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2014 | 4751 | 0.210 |
Why?
|
| Aged | 46 | 2021 | 162944 | 0.200 |
Why?
|
| Chromatin | 7 | 2014 | 2917 | 0.200 |
Why?
|
| Point Mutation | 7 | 2014 | 1624 | 0.200 |
Why?
|
| BK Virus | 1 | 2022 | 129 | 0.190 |
Why?
|
| Genotype | 13 | 2021 | 12946 | 0.190 |
Why?
|
| Methyltransferases | 1 | 2004 | 367 | 0.190 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2021 | 23 | 0.190 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 1195 | 0.190 |
Why?
|
| Multiprotein Complexes | 3 | 2013 | 1119 | 0.190 |
Why?
|
| Papillomaviridae | 4 | 2015 | 1118 | 0.190 |
Why?
|
| Protein Conformation | 8 | 2015 | 4013 | 0.190 |
Why?
|
| Bodily Secretions | 1 | 2020 | 23 | 0.190 |
Why?
|
| Carcinoma, Medullary | 1 | 2021 | 123 | 0.190 |
Why?
|
| 5' Untranslated Regions | 2 | 2020 | 249 | 0.190 |
Why?
|
| Tachykinins | 1 | 2021 | 78 | 0.190 |
Why?
|
| Gene Duplication | 3 | 2018 | 330 | 0.190 |
Why?
|
| Middle Aged | 46 | 2023 | 213127 | 0.190 |
Why?
|
| Gene Expression | 8 | 2016 | 7790 | 0.190 |
Why?
|
| Chemokine CXCL1 | 1 | 2020 | 101 | 0.190 |
Why?
|
| Genetics, Medical | 1 | 2003 | 337 | 0.190 |
Why?
|
| Wnt Proteins | 5 | 2018 | 721 | 0.180 |
Why?
|
| MicroRNAs | 7 | 2017 | 3731 | 0.180 |
Why?
|
| Gene Library | 5 | 2015 | 1076 | 0.180 |
Why?
|
| Genomic Islands | 1 | 2020 | 51 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2016 | 380 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2023 | 1631 | 0.180 |
Why?
|
| Antigens, Neoplasm | 3 | 2017 | 1983 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2023 | 462 | 0.180 |
Why?
|
| Oncogene Protein p21(ras) | 2 | 2009 | 82 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 2 | 2015 | 1040 | 0.170 |
Why?
|
| DNA Methylation | 11 | 2017 | 4282 | 0.170 |
Why?
|
| Latin America | 1 | 2020 | 381 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2010 | 2638 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2004 | 355 | 0.170 |
Why?
|
| Peptide Library | 1 | 2021 | 350 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7153 | 0.170 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2018 | 1596 | 0.170 |
Why?
|
| Retroviridae | 4 | 2012 | 914 | 0.170 |
Why?
|
| Jurkat Cells | 1 | 2021 | 742 | 0.170 |
Why?
|
| Models, Molecular | 13 | 2015 | 5454 | 0.170 |
Why?
|
| Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2019 | 96 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2019 | 4211 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 4 | 2015 | 1477 | 0.160 |
Why?
|
| Algorithms | 12 | 2022 | 13853 | 0.160 |
Why?
|
| Methylation | 4 | 2014 | 1107 | 0.160 |
Why?
|
| Virus Integration | 3 | 2018 | 297 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2000 | 374 | 0.160 |
Why?
|
| Survival Analysis | 9 | 2018 | 10248 | 0.160 |
Why?
|
| Neuroblastoma | 4 | 2013 | 1225 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2016 | 933 | 0.160 |
Why?
|
| Pyrimidines | 5 | 2018 | 2933 | 0.160 |
Why?
|
| Leukemia, Myeloid | 3 | 2014 | 705 | 0.160 |
Why?
|
| Cyanides | 1 | 2018 | 83 | 0.160 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2018 | 103 | 0.160 |
Why?
|
| Epoxy Compounds | 1 | 2018 | 136 | 0.160 |
Why?
|
| Bifidobacterium | 1 | 2018 | 100 | 0.160 |
Why?
|
| RNA Precursors | 2 | 2011 | 206 | 0.160 |
Why?
|
| Intestine, Small | 2 | 2015 | 1243 | 0.160 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 2 | 2019 | 508 | 0.160 |
Why?
|
| Prevotella | 1 | 2017 | 79 | 0.150 |
Why?
|
| Cells, Cultured | 10 | 2018 | 19223 | 0.150 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 206 | 0.150 |
Why?
|
| Trans-Activators | 5 | 2011 | 2924 | 0.150 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 57683 | 0.150 |
Why?
|
| Guanidines | 1 | 2018 | 191 | 0.150 |
Why?
|
| Microsatellite Instability | 2 | 2018 | 678 | 0.150 |
Why?
|
| Single-Cell Analysis | 4 | 2016 | 2183 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2021 | 704 | 0.150 |
Why?
|
| Genes, ras | 6 | 2012 | 691 | 0.150 |
Why?
|
| Karyopherins | 1 | 2018 | 132 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2009 | 892 | 0.150 |
Why?
|
| Neurofibromin 1 | 3 | 2013 | 196 | 0.150 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2012 | 434 | 0.150 |
Why?
|
| HT29 Cells | 1 | 2017 | 200 | 0.150 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2008 | 91 | 0.150 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2017 | 19 | 0.150 |
Why?
|
| Macrolides | 1 | 2018 | 201 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2020 | 9185 | 0.150 |
Why?
|
| Interleukin-8 | 1 | 2020 | 689 | 0.150 |
Why?
|
| Bacteroides | 1 | 2017 | 161 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2012 | 384 | 0.150 |
Why?
|
| Genetic Loci | 3 | 2018 | 2572 | 0.150 |
Why?
|
| Sulfonamides | 3 | 2018 | 1932 | 0.150 |
Why?
|
| Chromosomes, Human | 5 | 2014 | 457 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 3 | 2014 | 655 | 0.150 |
Why?
|
| DNA Primers | 3 | 2012 | 2892 | 0.150 |
Why?
|
| Cell Nucleus | 4 | 2023 | 2968 | 0.140 |
Why?
|
| Amino Acid Sequence | 12 | 2013 | 13814 | 0.140 |
Why?
|
| Mice, SCID | 4 | 2019 | 2715 | 0.140 |
Why?
|
| Cloning, Molecular | 5 | 2012 | 4322 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2014 | 375 | 0.140 |
Why?
|
| Cell Differentiation | 9 | 2013 | 11470 | 0.140 |
Why?
|
| Prognosis | 19 | 2021 | 29010 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.140 |
Why?
|
| Retinoblastoma Protein | 4 | 2013 | 701 | 0.140 |
Why?
|
| Oncogene Proteins | 4 | 2015 | 749 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 1655 | 0.140 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 161 | 0.140 |
Why?
|
| Cell Growth Processes | 3 | 2013 | 400 | 0.140 |
Why?
|
| Cytokines | 4 | 2021 | 7317 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 1470 | 0.140 |
Why?
|
| Spliceosomes | 2 | 2018 | 110 | 0.140 |
Why?
|
| Drug Delivery Systems | 3 | 2018 | 2217 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2013 | 131 | 0.140 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2699 | 0.140 |
Why?
|
| Membrane Proteins | 4 | 2019 | 7873 | 0.140 |
Why?
|
| RNA Polymerase II | 3 | 2011 | 550 | 0.140 |
Why?
|
| Adult | 38 | 2021 | 213712 | 0.140 |
Why?
|
| PC12 Cells | 2 | 2014 | 330 | 0.130 |
Why?
|
| Noonan Syndrome | 2 | 2008 | 120 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 577 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 567 | 0.130 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 516 | 0.130 |
Why?
|
| Consensus Sequence | 3 | 2020 | 377 | 0.130 |
Why?
|
| Islets of Langerhans | 2 | 2016 | 1351 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2013 | 67 | 0.130 |
Why?
|
| Oncogenic Viruses | 1 | 2015 | 42 | 0.130 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2014 | 290 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2018 | 6534 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 2014 | 17 | 0.130 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2016 | 271 | 0.130 |
Why?
|
| Anilides | 1 | 2018 | 404 | 0.130 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2015 | 38 | 0.130 |
Why?
|
| Adenoma, Islet Cell | 1 | 2014 | 82 | 0.130 |
Why?
|
| Thiazoles | 2 | 2013 | 1484 | 0.130 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4328 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2018 | 11472 | 0.130 |
Why?
|
| Phylogeny | 2 | 2013 | 2797 | 0.130 |
Why?
|
| Neoplasm, Residual | 1 | 2020 | 974 | 0.130 |
Why?
|
| Cisplatin | 2 | 2019 | 1637 | 0.130 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1284 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2023 | 895 | 0.130 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2008 | 1374 | 0.130 |
Why?
|
| Ploidies | 4 | 2013 | 281 | 0.130 |
Why?
|
| Angiomyolipoma | 1 | 2016 | 186 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2015 | 155 | 0.130 |
Why?
|
| Pyridines | 2 | 2018 | 2818 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 3612 | 0.130 |
Why?
|
| Cell Movement | 2 | 2020 | 5212 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 2 | 2013 | 96 | 0.120 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2015 | 84 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1699 | 0.120 |
Why?
|
| Pulmonary Blastoma | 1 | 2014 | 33 | 0.120 |
Why?
|
| Stomach Neoplasms | 2 | 2022 | 1327 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1060 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2019 | 314 | 0.120 |
Why?
|
| Genes, p16 | 2 | 2012 | 157 | 0.120 |
Why?
|
| Proto-Oncogene Proteins A-raf | 1 | 2014 | 9 | 0.120 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2015 | 118 | 0.120 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2016 | 162 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.120 |
Why?
|
| Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
| CDC2 Protein Kinase | 2 | 1992 | 220 | 0.120 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 299 | 0.120 |
Why?
|
| Intraoperative Period | 1 | 2015 | 520 | 0.120 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2014 | 154 | 0.120 |
Why?
|
| Neoplasm Staging | 11 | 2015 | 11001 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.120 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2016 | 210 | 0.120 |
Why?
|
| Dimerization | 2 | 2013 | 893 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2019 | 1382 | 0.120 |
Why?
|
| Receptor, trkB | 1 | 2014 | 125 | 0.120 |
Why?
|
| Sequence Alignment | 3 | 2012 | 2257 | 0.120 |
Why?
|
| Immunohistochemistry | 8 | 2018 | 11363 | 0.120 |
Why?
|
| Mexico | 2 | 2015 | 688 | 0.120 |
Why?
|
| Receptor, trkA | 1 | 2014 | 164 | 0.120 |
Why?
|
| Epithelial Cells | 3 | 2023 | 3678 | 0.120 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
| Cullin Proteins | 1 | 2014 | 180 | 0.120 |
Why?
|
| Oncogene Protein v-akt | 1 | 2013 | 135 | 0.120 |
Why?
|
| RNA, Viral | 2 | 2020 | 2899 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 603 | 0.120 |
Why?
|
| Models, Biological | 7 | 2012 | 9581 | 0.120 |
Why?
|
| Neurofibromin 2 | 1 | 2014 | 267 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2010 | 1727 | 0.110 |
Why?
|
| Skin Neoplasms | 4 | 2020 | 5662 | 0.110 |
Why?
|
| Cell Transformation, Viral | 1 | 2015 | 565 | 0.110 |
Why?
|
| Oncogene Fusion | 1 | 2013 | 99 | 0.110 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2014 | 185 | 0.110 |
Why?
|
| Gene Components | 1 | 2013 | 29 | 0.110 |
Why?
|
| Multiple Myeloma | 3 | 2018 | 5169 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 78 | 0.110 |
Why?
|
| Sirolimus | 3 | 2009 | 1562 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 345 | 0.110 |
Why?
|
| Temporal Arteries | 1 | 2014 | 128 | 0.110 |
Why?
|
| Liver Neoplasms | 4 | 2017 | 4249 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1118 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
| Genetic Markers | 4 | 2004 | 2633 | 0.110 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 10163 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2014 | 209 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2014 | 179 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2723 | 0.110 |
Why?
|
| Mice, Knockout | 7 | 2016 | 14554 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 9 | 2019 | 6313 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2016 | 880 | 0.110 |
Why?
|
| Cohort Studies | 10 | 2020 | 40450 | 0.110 |
Why?
|
| src-Family Kinases | 2 | 2015 | 551 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2011 | 234 | 0.110 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 20 | 0.110 |
Why?
|
| HLA-B Antigens | 1 | 2013 | 353 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2014 | 275 | 0.110 |
Why?
|
| Nucleic Acids | 1 | 2014 | 181 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 231 | 0.100 |
Why?
|
| F-Box Proteins | 1 | 2013 | 197 | 0.100 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 451 | 0.100 |
Why?
|
| Metagenome | 2 | 2014 | 417 | 0.100 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 1586 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 608 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2019 | 1707 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 489 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2011 | 13 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2013 | 199 | 0.100 |
Why?
|
| Intestine, Large | 1 | 2011 | 71 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2014 | 436 | 0.100 |
Why?
|
| Mediator Complex | 1 | 2012 | 109 | 0.100 |
Why?
|
| Niacinamide | 1 | 2014 | 416 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 2 | 2018 | 2458 | 0.100 |
Why?
|
| Sensitivity and Specificity | 9 | 2018 | 14720 | 0.100 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.100 |
Why?
|
| NFI Transcription Factors | 1 | 2011 | 44 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 2 | 2006 | 874 | 0.100 |
Why?
|
| Vietnam | 1 | 2012 | 408 | 0.100 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1991 | 113 | 0.100 |
Why?
|
| Totivirus | 1 | 2010 | 2 | 0.100 |
Why?
|
| Salmo salar | 1 | 2010 | 8 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 2015 | 316 | 0.100 |
Why?
|
| Reoviridae Infections | 1 | 2010 | 60 | 0.100 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 484 | 0.100 |
Why?
|
| Fish Diseases | 1 | 2010 | 38 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2013 | 1284 | 0.090 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 382 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2013 | 625 | 0.090 |
Why?
|
| Survival Rate | 8 | 2020 | 12773 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 526 | 0.090 |
Why?
|
| Phenotype | 7 | 2018 | 16331 | 0.090 |
Why?
|
| Tumor Escape | 1 | 2013 | 349 | 0.090 |
Why?
|
| Ultraviolet Rays | 2 | 2012 | 1059 | 0.090 |
Why?
|
| Triazoles | 2 | 2015 | 907 | 0.090 |
Why?
|
| Protein Biosynthesis | 4 | 2022 | 2126 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 748 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 474 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
| Human papillomavirus 18 | 1 | 2011 | 128 | 0.090 |
Why?
|
| Reoviridae | 1 | 2010 | 161 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 329 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 781 | 0.090 |
Why?
|
| Polyadenylation | 1 | 2011 | 116 | 0.090 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 12071 | 0.090 |
Why?
|
| Models, Genetic | 6 | 2013 | 3493 | 0.090 |
Why?
|
| Giant Cell Arteritis | 1 | 2014 | 292 | 0.090 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.090 |
Why?
|
| Biological Specimen Banks | 1 | 2015 | 707 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 1989 | 0.090 |
Why?
|
| Disease Progression | 8 | 2017 | 13256 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2020 | 2616 | 0.090 |
Why?
|
| Escherichia coli | 2 | 2020 | 4214 | 0.090 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 800 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1991 | 362 | 0.090 |
Why?
|
| Pleural Neoplasms | 1 | 2014 | 607 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1937 | 0.090 |
Why?
|
| Interleukin-3 | 5 | 2013 | 441 | 0.090 |
Why?
|
| Viruses | 2 | 2004 | 374 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2010 | 142 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2012 | 3001 | 0.090 |
Why?
|
| Receptor, erbB-3 | 1 | 2010 | 142 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2012 | 435 | 0.080 |
Why?
|
| Heterozygote | 4 | 2020 | 2790 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 2 | 2014 | 2712 | 0.080 |
Why?
|
| Homozygote | 4 | 2012 | 1777 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2005 | 53 | 0.080 |
Why?
|
| Cell Death | 3 | 2022 | 1695 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 4 | 2015 | 890 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 15056 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 628 | 0.080 |
Why?
|
| Biopsy | 4 | 2014 | 6756 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 782 | 0.080 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 68 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2372 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2014 | 818 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 171 | 0.080 |
Why?
|
| Barrett Esophagus | 2 | 2012 | 494 | 0.080 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2007 | 17 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2018 | 1434 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 502 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2016 | 1389 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1820 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1377 | 0.080 |
Why?
|
| Meningioma | 1 | 2017 | 1209 | 0.080 |
Why?
|
| Proto-Oncogenes | 2 | 2008 | 321 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2016 | 878 | 0.080 |
Why?
|
| Lysosomes | 1 | 2013 | 893 | 0.080 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2009 | 152 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 847 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4379 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2011 | 947 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 2211 | 0.080 |
Why?
|
| Octamer Transcription Factors | 1 | 2007 | 23 | 0.080 |
Why?
|
| HL-60 Cells | 2 | 2006 | 365 | 0.080 |
Why?
|
| Ligands | 3 | 2022 | 3293 | 0.080 |
Why?
|
| Pharmacogenetics | 3 | 2012 | 676 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 1860 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 1241 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 151 | 0.080 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2007 | 45 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2009 | 643 | 0.070 |
Why?
|
| Reproducibility of Results | 8 | 2018 | 19862 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 825 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.070 |
Why?
|
| Liposarcoma | 1 | 2010 | 333 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 814 | 0.070 |
Why?
|
| Staurosporine | 2 | 2007 | 251 | 0.070 |
Why?
|
| Amino Acids | 1 | 2013 | 1727 | 0.070 |
Why?
|
| Bronchial Neoplasms | 1 | 2007 | 112 | 0.070 |
Why?
|
| Crystallography, X-Ray | 4 | 2015 | 2014 | 0.070 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 360 | 0.070 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 162 | 0.070 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2007 | 98 | 0.070 |
Why?
|
| Colonic Neoplasms | 4 | 2013 | 2542 | 0.070 |
Why?
|
| Carrier Proteins | 4 | 2013 | 5019 | 0.070 |
Why?
|
| Diarrhea | 1 | 2013 | 1343 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2522 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2016 | 2941 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2005 | 46 | 0.070 |
Why?
|
| Clone Cells | 2 | 2021 | 1692 | 0.070 |
Why?
|
| Quinazolinones | 1 | 2007 | 221 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 251 | 0.070 |
Why?
|
| Survival | 1 | 2006 | 162 | 0.070 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 118 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.070 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 9735 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2008 | 3497 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2014 | 2295 | 0.060 |
Why?
|
| Rectum | 1 | 2020 | 903 | 0.060 |
Why?
|
| Deoxyribonuclease I | 1 | 2006 | 228 | 0.060 |
Why?
|
| Acute Disease | 2 | 2014 | 7141 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 453 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 936 | 0.060 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 6891 | 0.060 |
Why?
|
| Prospective Studies | 7 | 2020 | 53187 | 0.060 |
Why?
|
| Smoking | 6 | 2017 | 8969 | 0.060 |
Why?
|
| Bacillus Phages | 1 | 2004 | 12 | 0.060 |
Why?
|
| Gene Regulatory Networks | 4 | 2014 | 1707 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 562 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2015 | 459 | 0.060 |
Why?
|
| Papillomavirus Infections | 2 | 2013 | 1585 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2015 | 1970 | 0.060 |
Why?
|
| Genomic Library | 1 | 2004 | 193 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2018 | 21719 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 987 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8333 | 0.060 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 18006 | 0.060 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2008 | 299 | 0.060 |
Why?
|
| BRCA2 Protein | 2 | 2023 | 790 | 0.060 |
Why?
|
| Tissue Array Analysis | 3 | 2011 | 553 | 0.060 |
Why?
|
| DNA Helicases | 3 | 2016 | 861 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 103 | 0.060 |
Why?
|
| DNA | 3 | 2013 | 7289 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39004 | 0.060 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2005 | 166 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2015 | 7716 | 0.060 |
Why?
|
| Child | 13 | 2023 | 77478 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 3769 | 0.060 |
Why?
|
| Polycythemia Vera | 1 | 2005 | 163 | 0.060 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.060 |
Why?
|
| Hedgehog Proteins | 3 | 2012 | 781 | 0.060 |
Why?
|
| Drug Inverse Agonism | 1 | 2022 | 11 | 0.060 |
Why?
|
| Genes, Essential | 2 | 2016 | 182 | 0.060 |
Why?
|
| Mouth Neoplasms | 1 | 2008 | 601 | 0.060 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 4664 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2003 | 229 | 0.060 |
Why?
|
| Binding Sites | 5 | 2014 | 6115 | 0.060 |
Why?
|
| Human Genome Project | 1 | 2003 | 192 | 0.050 |
Why?
|
| Primary Myelofibrosis | 1 | 2005 | 214 | 0.050 |
Why?
|
| Peptide Mapping | 2 | 1994 | 263 | 0.050 |
Why?
|
| Indoles | 1 | 2011 | 1834 | 0.050 |
Why?
|
| Macromolecular Substances | 3 | 1998 | 1456 | 0.050 |
Why?
|
| Bacteria | 2 | 2022 | 2102 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 473 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2018 | 647 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4465 | 0.050 |
Why?
|
| Centromere | 1 | 2023 | 220 | 0.050 |
Why?
|
| BRCA1 Protein | 2 | 2023 | 1145 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 438 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2014 | 2224 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 2 | 2014 | 215 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2008 | 1608 | 0.050 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2021 | 94 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2023 | 338 | 0.050 |
Why?
|
| Simian virus 40 | 1 | 2022 | 295 | 0.050 |
Why?
|
| DNA Breaks | 1 | 2021 | 49 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2002 | 255 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 2024 | 0.050 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2021 | 39 | 0.050 |
Why?
|
| Laboratories | 1 | 2005 | 461 | 0.050 |
Why?
|
| Plasma Cells | 2 | 2016 | 592 | 0.050 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2021 | 91 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 484 | 0.050 |
Why?
|
| Markov Chains | 1 | 2004 | 969 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 2013 | 2951 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3381 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2011 | 462 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2013 | 2107 | 0.050 |
Why?
|
| Blotting, Western | 5 | 2006 | 5180 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2021 | 149 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1086 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2022 | 799 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2000 | 133 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2009 | 1802 | 0.050 |
Why?
|
| Endogenous Retroviruses | 1 | 2021 | 112 | 0.050 |
Why?
|
| Sample Size | 2 | 2014 | 844 | 0.050 |
Why?
|
| Chromosomes | 1 | 2023 | 595 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 6608 | 0.040 |
Why?
|
| Kenya | 1 | 2022 | 685 | 0.040 |
Why?
|
| Disulfiram | 1 | 2020 | 57 | 0.040 |
Why?
|
| Japan | 1 | 2004 | 1360 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 2203 | 0.040 |
Why?
|
| raf Kinases | 2 | 2011 | 122 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 289 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2021 | 228 | 0.040 |
Why?
|
| Rats | 2 | 2014 | 24265 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 2 | 2014 | 914 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 276 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 2721 | 0.040 |
Why?
|
| Histone Demethylases | 2 | 2012 | 320 | 0.040 |
Why?
|
| CpG Islands | 2 | 2015 | 1170 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2012 | 496 | 0.040 |
Why?
|
| Glucose | 1 | 2011 | 4391 | 0.040 |
Why?
|
| Treatment Outcome | 9 | 2018 | 62966 | 0.040 |
Why?
|
| Catalysis | 2 | 1998 | 760 | 0.040 |
Why?
|
| Retrospective Studies | 9 | 2023 | 77098 | 0.040 |
Why?
|
| Melanocytes | 2 | 2012 | 515 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1895 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 1912 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 21821 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 403 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 991 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 40054 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2013 | 2003 | 0.040 |
Why?
|
| Kinetics | 2 | 2021 | 6474 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 2005 | 829 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2021 | 573 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 399 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1546 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2021 | 686 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2020 | 229 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 193 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 2006 | 0.040 |
Why?
|
| Tennessee | 1 | 2017 | 117 | 0.040 |
Why?
|
| NF-kappa B | 3 | 2012 | 2500 | 0.040 |
Why?
|
| Probability | 3 | 2007 | 2502 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3502 | 0.040 |
Why?
|
| Cell Shape | 1 | 2018 | 375 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 341 | 0.040 |
Why?
|
| DNA Repair | 2 | 2020 | 2042 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9274 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2017 | 274 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 10392 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2015 | 1907 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2021 | 40955 | 0.040 |
Why?
|
| Symbiosis | 1 | 2019 | 283 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2016 | 58 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1341 | 0.030 |
Why?
|
| Panama | 1 | 2015 | 30 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2011 | 6191 | 0.030 |
Why?
|
| E2F3 Transcription Factor | 1 | 2015 | 40 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2015 | 3587 | 0.030 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2015 | 25 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2018 | 865 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 177 | 0.030 |
Why?
|
| Documentation | 1 | 2021 | 865 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 1884 | 0.030 |
Why?
|
| Hong Kong | 1 | 2015 | 148 | 0.030 |
Why?
|
| Peptides | 2 | 2020 | 4392 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
| Moraxellaceae Infections | 1 | 2014 | 8 | 0.030 |
Why?
|
| Young Adult | 6 | 2021 | 56350 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1875 | 0.030 |
Why?
|
| Chromatiaceae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Prevalence | 2 | 2017 | 15194 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 571 | 0.030 |
Why?
|
| Argentina | 1 | 2015 | 232 | 0.030 |
Why?
|
| Colombia | 1 | 2015 | 259 | 0.030 |
Why?
|
| Propionibacterium acnes | 1 | 2014 | 66 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 1998 | 454 | 0.030 |
Why?
|
| Adolescent | 6 | 2021 | 85649 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 766 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 1994 | 55 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2014 | 76 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5095 | 0.030 |
Why?
|
| Forecasting | 1 | 2003 | 2948 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 1994 | 101 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1997 | 2749 | 0.030 |
Why?
|
| United States | 3 | 2014 | 69693 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 366 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2014 | 256 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2013 | 91 | 0.030 |
Why?
|
| S Phase | 1 | 2015 | 423 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2015 | 236 | 0.030 |
Why?
|
| Thiophenes | 1 | 2018 | 590 | 0.030 |
Why?
|
| Testis | 1 | 1997 | 800 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2013 | 2303 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 589 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2009 | 1372 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 933 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2004 | 4143 | 0.030 |
Why?
|
| Azepines | 1 | 2015 | 336 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 972 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2005 | 251 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2018 | 802 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 402 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 808 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1782 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 223 | 0.030 |
Why?
|
| Mutagens | 1 | 2013 | 168 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 35342 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 117 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 442 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2012 | 2867 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 808 | 0.030 |
Why?
|
| Drug Design | 2 | 2013 | 1078 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 900 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2015 | 323 | 0.030 |
Why?
|
| Hemizygote | 1 | 2012 | 28 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2013 | 133 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 5519 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 107 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 1532 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2008 | 491 | 0.030 |
Why?
|
| Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
| Risk Factors | 3 | 2011 | 72145 | 0.030 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2012 | 18 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 815 | 0.030 |
Why?
|
| Cell Division | 3 | 2007 | 4564 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2012 | 151 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2012 | 109 | 0.030 |
Why?
|
| Protamine Kinase | 1 | 1991 | 12 | 0.030 |
Why?
|
| Polyploidy | 1 | 2012 | 114 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 1994 | 517 | 0.030 |
Why?
|
| TCF Transcription Factors | 1 | 2012 | 140 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 881 | 0.030 |
Why?
|
| Adenovirus Early Proteins | 1 | 1991 | 57 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5062 | 0.030 |
Why?
|
| Proteomics | 1 | 2005 | 3618 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2013 | 538 | 0.030 |
Why?
|
| ROC Curve | 2 | 2011 | 3528 | 0.030 |
Why?
|
| Benzoquinones | 1 | 2012 | 201 | 0.030 |
Why?
|
| Indazoles | 1 | 2013 | 287 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1992 | 561 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 242 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2010 | 1950 | 0.030 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 11 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 341 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 251 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 236 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1991 | 191 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2017 | 1171 | 0.020 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 116 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 197 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 365 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 351 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 170 | 0.020 |
Why?
|
| HMGA2 Protein | 1 | 2011 | 123 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 981 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2012 | 319 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 337 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 556 | 0.020 |
Why?
|
| Lung | 3 | 2019 | 9826 | 0.020 |
Why?
|
| Immune Evasion | 1 | 2014 | 360 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2011 | 287 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 532 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1509 | 0.020 |
Why?
|
| Biotechnology | 1 | 2012 | 278 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2013 | 675 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 2012 | 7901 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 209 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 598 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2013 | 670 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 497 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 471 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2013 | 1183 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 718 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 390 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 427 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2440 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2010 | 288 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2012 | 642 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2009 | 53 | 0.020 |
Why?
|
| Incidence | 2 | 2020 | 20928 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 1160 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 814 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2009 | 242 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2010 | 171 | 0.020 |
Why?
|
| Nomograms | 1 | 2011 | 224 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 2011 | 3584 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1991 | 2255 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 2186 | 0.020 |
Why?
|
| Stathmin | 1 | 2009 | 71 | 0.020 |
Why?
|
| Vinblastine | 1 | 2010 | 490 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2015 | 569 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2008 | 52 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 697 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 1723 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1794 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2012 | 5975 | 0.020 |
Why?
|
| Stomach | 1 | 2013 | 697 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2900 | 0.020 |
Why?
|
| Cyclin E | 1 | 2009 | 172 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 572 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 632 | 0.020 |
Why?
|
| Angiography | 1 | 1994 | 1636 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10943 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Systems Integration | 1 | 2010 | 440 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 86 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 611 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8621 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 321 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 3770 | 0.020 |
Why?
|
| Research Design | 2 | 2015 | 5979 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 191 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2010 | 437 | 0.020 |
Why?
|
| Genes | 1 | 1991 | 1892 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1827 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 287 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 512 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 975 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2009 | 336 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 71 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 795 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 1460 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2009 | 644 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1294 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 90 | 0.020 |
Why?
|
| Neutrophils | 1 | 2019 | 3711 | 0.020 |
Why?
|
| Cell Separation | 1 | 2012 | 1749 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1849 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 902 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 692 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 1397 | 0.020 |
Why?
|
| Pheochromocytoma | 1 | 2008 | 337 | 0.020 |
Why?
|
| Bronchi | 1 | 2009 | 840 | 0.020 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2005 | 46 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12958 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3070 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3520 | 0.020 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2004 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 148 | 0.020 |
Why?
|
| Microscopy | 1 | 2010 | 903 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 873 | 0.020 |
Why?
|
| Risk | 2 | 2008 | 9679 | 0.020 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2005 | 111 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6382 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 2039 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3139 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1675 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1126 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 898 | 0.020 |
Why?
|
| Models, Structural | 1 | 2005 | 361 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2005 | 259 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12242 | 0.020 |
Why?
|
| Infant | 3 | 2014 | 35070 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2005 | 169 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 500 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1599 | 0.020 |
Why?
|
| Artifacts | 1 | 2013 | 1903 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18355 | 0.020 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2004 | 27 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2006 | 353 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9305 | 0.010 |
Why?
|
| Hepatitis B, Chronic | 1 | 2008 | 393 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 293 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3465 | 0.010 |
Why?
|
| Aging | 2 | 2013 | 8626 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 364 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2013 | 2066 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 203 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 443 | 0.010 |
Why?
|
| Purines | 1 | 2007 | 593 | 0.010 |
Why?
|
| Proteome | 1 | 2013 | 1790 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 733 | 0.010 |
Why?
|
| Models, Statistical | 2 | 2008 | 5100 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13403 | 0.010 |
Why?
|
| Granulocytes | 1 | 2005 | 546 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 480 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 363 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 319 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 709 | 0.010 |
Why?
|
| Adenoma | 1 | 2013 | 2168 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3062 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2723 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 434 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1202 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3471 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2005 | 527 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2382 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2014 | 23320 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2837 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1994 | 2370 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1458 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12344 | 0.010 |
Why?
|
| Hepatitis C, Chronic | 1 | 2008 | 1027 | 0.010 |
Why?
|
| Homeostasis | 1 | 2011 | 3335 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 1208 | 0.010 |
Why?
|
| Astrocytes | 1 | 2006 | 1266 | 0.010 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2513 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1684 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.010 |
Why?
|
| Myocardium | 1 | 2010 | 4775 | 0.010 |
Why?
|
| Heart | 1 | 2010 | 4462 | 0.010 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1999 | 615 | 0.010 |
Why?
|
| Prostate | 1 | 2004 | 1764 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2009 | 2274 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3439 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 10578 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7167 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 3420 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1994 | 2027 | 0.010 |
Why?
|
| Neurons | 1 | 2008 | 9325 | 0.010 |
Why?
|